Effect of colesevelam hydrochloride on glycemia and insulin sensitivity in men with the metabolic syndrome

American Journal of Cardiology

Volumn 108, Issue 8, 2011, Pages 1129-1135

  Vega, Gloria Lena ^a,b   Dunn, Fredrick L ^a,b,c   Grundy, Scott M ^a,b,c  

^a Veterans Affairs North Texas Health Care System   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLESEVELAM; PLACEBO; SIMVASTATIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EVENING DOSAGE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN SENSITIVITY; MALE; METABOLIC SYNDROME X; MORNING DOSAGE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT DURATION;

ADULT; AGED; ALLYLAMINE; ANTICHOLESTEREMIC AGENTS; BLOOD GLUCOSE; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FOLLOW-UP STUDIES; GLUCOSE TOLERANCE TEST; HUMANS; HYPERGLYCEMIA; INSULIN; INSULIN RESISTANCE; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; TREATMENT OUTCOME;

EID: 80053954040     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.06.011     Document Type: Article

References (27)

1. A. Garg, and S.M. Grundy Cholestyramine therapy for dyslipidemia in non-insulin-dependent diabetes mellitus: a short-term, double-blind, crossover trial Ann Intern Med 121 1994 416 422
2. F.J. Zieve, M.F. Kalin, S.L. Schwartz, M.R. Jones, and W.L. Bailey Results of the glucose-lowering effect of WelChol study (GLOWS): a randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes Clin Ther 29 2007 74 83 (Pubitemid 46414026)
3. T. Yamakawa, T. Takano, H. Utsunomiya, K. Kadonosono, and A. Okamura Effect of colestimide therapy for glycemic control in type 2 diabetes mellitus with hypercholesterolemia Endocr J 54 2007 53 58 (Pubitemid 46481671)
4. R.B. Goldberg, V.A. Fonseca, K.E. Truitt, and M.R. Jones Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy Arch Intern Med 168 2008 1531 1540
5. V.A. Fonseca, J. Rosenstock, A.C. Wang, K.E. Truitt, and M.R. Jones Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy Diabetes Care 31 2008 1479 1484
6. H.E. Bays, R.B. Goldberg, K.E. Truitt, and M.R. Jones Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects Arch Intern Med 168 2008 1975 1983
7. K. Tziomalos, V.G. Athyros, and D.P. Mikhailidis Colesevelam improves glycemic control and lipid management in inadequately controlled type 2 diabetes mellitus Nat Clin Pract Endocrinol Metab 5 2009 16 17
8. J. Rosenstock, V.A. Fonseca, W.T. Garvey, R.B. Goldberg, Y. Handelsman, S.L. Abby, Y.L. Lai, X. Jin, S. Misir, S. Nagendran, and M.R. Jones Initial combination therapy with metformin and colesevelam for achievement of glycemic and lipid goals in early type 2 diabetes Endocr Pract 16 2010 629 640
9. I. Jialal, S.L. Abby, S. Misir, and S. Nagendran Concomitant reduction in low-density lipoprotein cholesterol and glycated hemoglobin with colesevelam hydrochloride in patients with type 2 diabetes: a pooled analysis Metab Syndr Relat Disord 7 2009 255 258
10. Y. Handelsman, R.B. Goldberg, W.T. Garvey, V.A. Fonseca, J. Rosenstock, M.R. Jones, Y.L. Lai, X. Jin, S. Misir, S. Nagendran, and S.L. Abby Colesevelam hydrochloride to treat hypercholesterolemia and improve glycemia in prediabetes: a randomized, prospective study Endocr Pract 16 2010 617 628
11. P. Levy, and P.S. Jellinger The potential role of colesevelam in the management of prediabetes and type 2 diabetes mellitus Postgrad Med 122 suppl 3 2010 1 8
12. S.M. Rivers, M.P. Kane, R.S. Busch, G. Bakst, and R.A. Hamilton Colesevelam hydrochloride-ezetimibe combination lipid-lowering therapy in patients with diabetes or metabolic syndrome and a history of statin intolerance Endocr Pract 13 2007 11 16
13. A. Mari, G. Pacini, E. Murphy, B. Ludvik, and J.J. Nolan A model-based method for assessing insulin sensitivity from the oral glucose tolerance test Diabetes Care 24 2001 539 548 (Pubitemid 32198427)
14. S.M. Grundy, H.B. Brewer Jr, J.I. Cleeman, S.C. Smith Jr, C. Lenfant American Heart Association, National Heart, Lung and Blood Institute Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition Circulation 109 2004 433 438 (Pubitemid 38133916)
15. Executive summary: standards of medical care in diabetes 2009 Diabetes Care;32(suppl 1):S6S12. Erratum Diabetes Care 32 2009 754
16. Executive summary: Standards of medical care in diabetes 2010. Diabetes Care; 33(suppl 1):S4S10.
17. H. Buchwald, R.L. Varco, J.P. Matts, J.M. Long, L.L. Fitch, G.S. Campbell, M.B. Pearce, A.E. Yellin, W.A. Edmiston, and R.D. Smink Jr Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia: report of the Program on the Surgical Control of the Hyperlipidemias (POSCH) N Engl J Med 323 1990 946 955 (Pubitemid 20332334)
18. P.T. Kovanen, D.W. Bilheimer, J.L. Goldstein, J.J. Jaramillo, and M.S. Brown Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog Proc Natl Acad Sci U S A 78 1981 1194 1198 (Pubitemid 11102187)
19. D.W. Bilheimer, S.M. Grundy, M.S. Brown, and J.L. Goldstein Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes Proc Natl Acad Sci U S A 80 1983 4124 4128
20. J.L. Witztum, S.G. Young, R.L. Elam, T.E. Carew, and M. Fisher Cholestyramine-induced changes in low density lipoprotein composition and metabolism I. Studies in the guinea pig J Lipid Res 26 1985 92 103 (Pubitemid 15133298)
21. S.G. Young, J.L. Witztum, T.E. Carew, R.W. Krauss, and F.T. Lindgren Colestipol-induced changes in LDL composition and metabolism II. Studies in humans J Lipid Res 30 1989 225 238 (Pubitemid 19067228)
22. P. Deedwania, P. Barter, R. Carmena, J.C. Fruchart, S.M. Grundy, S. Haffner, J.J. Kastelein, J.C. LaRosa, H. Schachner, J. Shepherd, D.D. Waters Treating to New Targets Investigators Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study Lancet 368 2006 919 928 (Pubitemid 44331360)
23. Z.T. Bloomgarden, R. Dodis, C.M. Viscoli, E.S. Holmboe, and S.E. Inzucchi Lower baseline glycemia reduces apparent oral agent glucose-lowering efficacy: a meta-regression analysis Diabetes Care 29 2006 2137 2139 (Pubitemid 44871202)
24. Y. Handelsman, S.L. Abby, X. Jin, J.M. Donovan, and M.R. Jones Colesevelam HCl improves fasting plasma glucose and lipid levels in patients with prediabetes Postgrad Med 12 2009 62 69
25. R.A. DeFronzo, E. Ferrannini, and D.C. Simonson Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake Metabolism 38 1989 387 395 (Pubitemid 19105727)
26. K.F. Petersen, D. Laurent, D.L. Rothman, G.W. Cline, and G.I. Shulman Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans J Clin Invest 10 1998 1203 1209 (Pubitemid 28145235)
27. M. Roden, K.F. Petersen, and G.I. Shulman Nuclear magnetic resonance studies of hepatic glucose metabolism in humans Recent Prog Horm Res 56 2001 219 237